HEMOGLOBIN COMPOSITION WITH REDUCED SIDE EFFECT

PROBLEM TO BE SOLVED: To provide a new hemoglobin composition, especially a new recombinant mutant hemoglobin composition, which excludes or substantially reduces (1) generation of heart injury, (2) discomfort of digestive tract, (3) pressor effect, and (4) endotoxin hypersensitivity, associated wit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SCHICK MICHAEL R, FOSTER DAVID L, TRIMBLE STEPHEN P, LEMON DOUGLAS D, APOSTOL IZYDOR Z, HARTMAN JAMES C, MOORE EDWIN G, PEREIRA DAVID, RICHARDS JANE P, BURHOP KENNETH E, LEE GEOFFREY F, DOYLE MICHAEL P, BRUCKER ERIC A, LOOKER DOUGLAS L, HAI TON-THAT, GLASCOCK CHRISTOPHER B
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:PROBLEM TO BE SOLVED: To provide a new hemoglobin composition, especially a new recombinant mutant hemoglobin composition, which excludes or substantially reduces (1) generation of heart injury, (2) discomfort of digestive tract, (3) pressor effect, and (4) endotoxin hypersensitivity, associated with the administration of an extracellular hemoglobin composition in various therapeutic applications. SOLUTION: Applications described include: treatments for anemia, heart injury, hemorrhage or hypovolemia, ischemia, cachexia, sickle cell crisis and stroke; enhancement in cancer treatments; stimulation of hematopoiesis; improvement in repair of physically damaged tissues; alleviation of cardiogenic shock; and shock resuscitation. COPYRIGHT: (C)2011,JPO&INPIT